Integra LifeSciences Holdings Corp. (IART)
13.58
-0.28
(-2.02%)
USD |
NASDAQ |
Jan 09, 16:00
13.58
0.00 (0.00%)
After-Hours: 20:00
Integra LifeSciences Holdings Research and Development Expense (Annual): 54.43M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Clearpoint Neuro, Inc. | 12.39M |
| Tandem Diabetes Care, Inc. | 184.17M |
| iRhythm Technologies, Inc. | 71.46M |
| Perspective Therapeutics, Inc. | 39.33M |
| InfuSystem Holdings, Inc. | -- |